Solicitation - Notice of Intent to SS CVM127318.pdf
PDF 68 KB Posted
- Attached to
- Genotyping Services of Mice
- Solicitation number
- RFQ-CVM-25-127318
About this file
This document is a Notice of Intent to Sole Source for genetic services issued by the Food and Drug Administration (FDA) on July 2, 2025. The FDA intends to award a Firm Fixed Price contract to Transnetyx, Inc. for genotyping and SNP analysis of mice, under solicitation FDA_CVM127318. The procurement is being pursued under FAR Part 6.302-1(a)(2)(ii), which allows for a sole source award when only one responsible source can satisfy agency requirements.
The notice invites other potential vendors to submit capability statements demonstrating their ability to perform the genetic services by July 11, 2025, at 3:00 PM EST. While the FDA anticipates awarding the contract to Transnetyx within 10 days, they will review any submitted capability statements to determine if the requirement could be competitively awarded. The minimum requirements are referenced in an attached Statement of Work, and interested parties should email their responses to Rodney D. Aytch at rodney.aytch@fda.hhs.gov. The contract involves analyzing up to 1,400 samples to ensure correct mouse genotypes and genetic backgrounds for future experiments.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
July 2, 2025
Notice of Intent to Sole Source
Procurement of Genetic Services (genotyping and SNP Analysis) of mice
FDA_CVM127318
The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to
Transnetyx, Inc., at 8110 Cordova Rd., STE 119, Cordova, TN 38016-0552.
In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.
The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.
MINIMUM REQUIREMENTS:
See Attached Statement of Work
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the
Government.
It is anticipated that an award will be issued to Transnetyx, Inc., within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: July 11, 2025, by 3.00PM EST. Please email responses to Rodney D. Aytch – rodney.aytch@fda.hhs.gov.
Rodney D. Aytch
Contract Specialist mailto:rodney.aytch@fda.hhs.gov.
File details come from the government source that posted it. Updated .